The market cap does in no way represent the pipeline. Particularly now that we have evidence to that the CarT drug is working.
Share holders can hold and accumulate easier now after this derisking. The rest of the week will be interesting to watch as the news filters through. I dont expect a rerate, but will be interesting to see if the seller holder the price down stays around.
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial, page-42
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $8.776M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 0.9¢ | $59.35K | 5.993M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 6718821 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1317893 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| CHM (ASX) Chart |